Grufity logo
Grufity logo
EKSO

EKSO - Ekso Bionics Holdings Inc Stock Price, Fair Value and News

$18.81-0.19 (-1.00%)
Delayed as of 14 Sep 2026, 03:59 pm ET

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

EKSO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

EKSO Price Action

Last 7 days

-6.2%

Last 30 days

-8.6%

Last 90 days

3.5%

Trailing 12 Months

384.7%

EKSO RSI Chart

EKSO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

EKSO Valuation

Market Cap

2.8B

Price/Earnings (Trailing)

-54.83

Price/Sales (Trailing)

238.57

EV/EBITDA

65.57

Price/Free Cashflow

70.95

EKSO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

EKSO Fundamentals

EKSO Revenue

Revenue (TTM)

11.6M

Rev. Growth (Yr)

-36.56%

Rev. Growth (Qtr)

-31.82%

EKSO Earnings

Earnings (TTM)

-50.3M

Earnings Growth (Yr)

-138.15%

Earnings Growth (Qtr)

-47.3%

EKSO Profitability

EBT Margin

-101.12%

Return on Equity

-27.95%

Return on Assets

-15.44%

Free Cashflow Yield

1.41%

EKSO Investor Care

Shares Dilution (1Y)

110.45%

Diluted EPS (TTM)

-0.36

Revenue & Growth

How Ekso Bionics Holdings Inc generates revenue and covers its expenses, based on the latest reported earnings.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
202611.6M---
202517.5M14.7M14.7M12.8M
202417.9M18.2M17.7M17.9M
202314.4M15.8M17.1M18.3M
202211.9M13.0M13.3M12.8M
20218.2M8.1M8.3M11.2M
202011.8M10.8M10.3M7.8M
201912.4M12.7M13.5M13.9M
20188.4M9.5M10.5M11.3M
20177.2M7.5M7.5M7.4M
201615.5M14.9M13.6M14.2M
20156.0M6.9M8.2M8.7M
20143.7M3.9M4.6M5.3M
20132.9M3.0M3.2M3.3M
2012---2.7M
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Ekso Bionics Holdings Inc

EKSO
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therap, an adjustable and lower-limb powered exoskeleton; and Ekso Indego Personal, a powered lower limb orthosis. It has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in San Rafael, California.
 CEO
 WEBSITEeksobionics.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES72

Ekso Bionics Holdings Inc Frequently Asked Questions

EKSO is the stock ticker symbol of Ekso Bionics Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Sep 11 2026, market cap of Ekso Bionics Holdings Inc is 2.76 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Sep 11 2026, EKSO's PE ratio (Price to Earnings) is -54.83 and Price to Sales (PS) ratio is 238.57. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EKSO PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Ekso Bionics Holdings Inc has provided -0.315 (multiply by 100 for percentage) rate of return.